Tag: Immune-checkpoint inhibitor (ICI)

Immune-checkpoint inhibitors (ICIs) have significantly improved outcomes in a variety of malignancies. Immune-related adverse events, however, are common and may lead to treatment discontinuation and adverse events. Immune-related cutaneous adverse events (ircAEs) are the most frequent and earliest to develop, but there is no evidence-based consensus regarding the management...
Association Between Preoperative Opioid and Benzodiazepine Prescription Patterns and Mortality After Noncardiac Surgery Strategies to amend clinician prescription patterns are of critical importance in addressing opioid abuse and opioid-related deaths across the United States. One potential approach involves targeting opioid-prescription practices in the perioperative period. However, little is known about...